Advertisement

COPD pp 313-320 | Cite as

Cohort Study in COPD: Introduction to COPD Cohorts (The KOLD and COPDGene Study) and Collaborative Approaches

  • Deog Kyeom KimEmail author
Chapter
  • 1.1k Downloads

Abstract

COPD is regarded as an umbrella term containing heterogeneous clinical, radiographic, and physiological features. Heterogeneous phenotypes and even endotypes of COPD have been identified and characterized through various COPD cohort studies.

While observational cohorts including birth cohorts may have merits on identifying etiologic exposure and incidence of targeted disease, majority of currently active COPD cohorts showed great outcomes in clarifying the clinical characteristics of COPD. Additionally combining case-control design and comparing with the healthy smokers, they revealed new findings contributing to the development and disease progression of COPD.

KOLD (Korean Obstructive Lung Disease) study is the first large well-organized Korean COPD cohort and COPDGene study is one of the largest studies to investigate the genetic factors of COPD in Americans. The KOLD and COPDGene are leading long-term prospective cohort investigating heterogeneity of COPD in Asia and America. A lot of clinical, radiographic, and genomic studies can be performed through these COPD cohorts.

Despite the contribution of current COPD cohorts, a collaborative cohort study has become to be mandatory in COPD research area to overcome the heterogeneity of COPD and achieve the sufficient statistical power based on the technical advances and expansion of our knowledge on COPD. Collaboration among cohort study can be activated entire the course of cohort study from designing the cohort to final analysis, and the collaborative approaches are expected to compensate the limitations of current COPD cohorts.

References

  1. 1.
    Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc. 2007;4:522–5.CrossRefGoogle Scholar
  2. 2.
    Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Evaluation of CLtIPSEi. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.CrossRefGoogle Scholar
  3. 3.
    Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, MacNee W, Miller B, Rennard SI, Silverman EK, Yates JC, Tal-Singer R. Evaluation of CLtIPSESI. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med. 2014;189:1022–30.CrossRefGoogle Scholar
  4. 4.
    Rennard SI. The promise of observational studies (ECLIPSE, SPIROMICS, and COPDGene) in achieving the goal of personalized treatment of chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2015;36:478–90.CrossRefGoogle Scholar
  5. 5.
    Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598–604.CrossRefGoogle Scholar
  6. 6.
    Park TS, Lee JS, Seo JB, Hong Y, Yoo JW, Kang BJ, Lee SW, Oh YM, Lee SD, Group KS. Study design and outcomes of Korean Obstructive Lung Disease (KOLD) cohort study. Tuberc Respir Dis (Seoul). 2014;76:169–74.CrossRefGoogle Scholar
  7. 7.
    Jo KW, Ra SW, Chae EJ, Seo JB, Kim NK, Lee JH, Kim EK, Lee YK, Kim TH, Huh JW, Kim WJ, Lee JH, Lee SM, Lim SY, Shin TR, Yoon HI, Sheen SS, Lee JS, Lee SD, Oh YM. Three phenotypes of obstructive lung disease in the elderly. Int J Tuberc Lung Dis. 2010;14:1481–8.PubMedGoogle Scholar
  8. 8.
    Chae EJ, Seo JB, Song JW, Kim N, Park BW, Lee YK, Oh YM, Lee SD, Lim SY. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol. 2010;194:W248–55.CrossRefGoogle Scholar
  9. 9.
    Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD, Group KS. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186:157–65.CrossRefGoogle Scholar
  10. 10.
    Lee JS, Huh JW, Chae EJ, Seo JB, Ra SW, Lee JH, Kim EK, Lee YK, Kim TH, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Oh YM, Lee SD. Different therapeutic responses in chronic obstructive pulmonary disease subgroups. Int J Tuberc Lung Dis. 2011;15:1104–10.CrossRefGoogle Scholar
  11. 11.
    Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Kim N, Seo JB, Oh YM, Lee SD. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2010;104:542–9.CrossRefGoogle Scholar
  12. 12.
    Lee JH, Oh YM, Seo JB, Lee YK, Kim WJ, Sheen SS, Kim TH, Lee JH, Kim EK, Lee JS, Huh JW, Lim SY, Yoon HI, Shin TR, Lee SM, Lee SY, Lee SD. Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia. Int J Tuberc Lung Dis. 2011;15:830–7.CrossRefGoogle Scholar
  13. 13.
    Kim WJ, Lee MK, Shin C, Cho NH, Lee SD, Oh YM, Sung J. Genome-wide association studies identify locus on 6p21 influencing lung function in the Korean population. Respirology. 2014;19:360–8.CrossRefGoogle Scholar
  14. 14.
    Kim WJ, Lim MN, Hong Y, Silverman EK, Lee JH, Jung BH, Ra SW, Choi HS, Jung YJ, Park YB, Park MJ, Lee SW, Lee JS, Oh YM, Lee SD. Association of lung function genes with chronic obstructive pulmonary disease. Lung. 2014;192:473–80.CrossRefGoogle Scholar
  15. 15.
    Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Kwon SY, Lee SD. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung. 2008;186:381–6.CrossRefGoogle Scholar
  16. 16.
    Kim WJ, Oh YM, Sung J, Lee YK, Seo JB, Kim N, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Kwon SY, Lee SD. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med. 2009;103:98–103.CrossRefGoogle Scholar
  17. 17.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology. 2009;14:260–3.CrossRefGoogle Scholar
  18. 18.
    Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7:32–43.CrossRefGoogle Scholar
  19. 19.
    Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agusti A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, Rennard S, Litonjua A, Qiu W, Beaty TH, Crapo JD, Riley JH, Tal-Singer R, Silverman EK, Eclipse I, Investigators CO. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:1238–47.CrossRefGoogle Scholar
  20. 20.
    Kim DK, Hersh CP, Washko GR, Hokanson JE, Lynch DA, Newell JD, Murphy JR, Crapo JD, Silverman EK, Investigators CG. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res. 2011;12:9.CrossRefGoogle Scholar
  21. 21.
    Wan ES, Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Won S, Lange C, Pillai SG, Anderson WH, Kong X, Lomas DA, Bakke PS, Gulsvik A, Regan EA, Murphy JR, Make BJ, Crapo JD, Wouters EF, Celli BR, Silverman EK, DeMeo DL, Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate E-P, Norway-Bergen C, National Emphysema Treatment T, investigators CG. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2011;45:304–10.CrossRefGoogle Scholar
  22. 22.
    Kim WJ, Hoffman E, Reilly J, Hersh C, Demeo D, Washko G, Silverman EK. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J. 2011;37:39–43.CrossRefGoogle Scholar
  23. 23.
    Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, Lange C, Won S, Murphy JR, Beaty TH, Regan EA, Make BJ, Hokanson JE, Crapo JD, Kong X, Anderson WH, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Pillai SG, Silverman EK. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010;42:200–2.CrossRefGoogle Scholar
  24. 24.
    Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB, Investigators I. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5:e1000421.CrossRefGoogle Scholar
  25. 25.
    Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galban S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711–5.CrossRefGoogle Scholar
  26. 26.
    Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT, Investigators CO, Investigators ES. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367:913–21.CrossRefGoogle Scholar
  27. 27.
    Diaz AA, Come CE, Ross JC, San Jose Estepar R, Han MK, Loring SH, Silverman EK, Washko GR, Investigators CO. Association between airway caliber changes with lung inflation and emphysema assessed by volumetric CT scan in subjects with COPD. Chest. 2012;141:736–44.CrossRefGoogle Scholar
  28. 28.
    Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estepar RS, Lynch DA, Brehm JM, Andriole KP, Diaz AA, Khorasani R, D'Aco K, Sciurba FC, Silverman EK, Hatabu H, Rosas IO, Investigators CO. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897–906.CrossRefGoogle Scholar
  29. 29.
    Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ, Investigators CO. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study. Chest. 2011;140:626–33.CrossRefGoogle Scholar
  30. 30.
    Wain LV, Shrine N, Miller S, Jackson VE, Ntalla I, Artigas MS, Billington CK, Kheirallah AK, Allen R, Cook JP, Probert K, Obeidat M, Bosse Y, Hao K, Postma DS, Pare PD, Ramasamy A, Consortium UKBE, Magi R, Mihailov E, Reinmaa E, Melen E, O’Connell J, Frangou E, Delaneau O, OxGSKC, Freeman C, Petkova D, McCarthy M, Sayers I, Deloukas P, Hubbard R, Pavord I, Hansell AL, Thomson NC, Zeggini E, Morris AP, Marchini J, Strachan DP, Tobin MD, Hall IP. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med. 2015;3(10):769–81.CrossRefGoogle Scholar
  31. 31.
    Moonesinghe R, Khoury MJ, Liu T, Ioannidis JP. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A. 2008;105:617–22.CrossRefGoogle Scholar
  32. 32.
    Silverman EK, Vestbo J, Agusti A, Anderson W, Bakke PS, Barnes KC, Barr RG, Bleecker ER, Boezen HM, Burkart KM, Celli BR, Cho MH, Cookson WO, Croxton T, Daley D, DL DM, Gan W, Garcia-Aymerich J, Hall IP, Hansel NN, Hersh CP, Kalsheker N, Kiley JP, Kim WJ, Lambrechts D, Lee SD, Litonjua AA, Lomas DA, London SJ, Nishimura M, Nordestgaard BG, O’Donnell CJ, Postma DS, Puhan MA, Tesfaigzi Y, Tobin MD, Vogelmeier C, Wilk JB, Wouters E, Young RP, Ziegler-Heitbrock L, MacNee W, Crapo JD. Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD. 2011;8:121–35.CrossRefGoogle Scholar
  33. 33.
    Psaty BM, Sitlani C. The ohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium as a model of collaborative science. Epidemiology. 2013;24:346–8.CrossRefGoogle Scholar
  34. 34.
    Loh LC, Oh YM, Lee SD. The Asian Network for Obstructive Lung Disease (ANOLD)-COPD from an Asian perspective. QJM. 2015;108(12):921–2.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care Medicine, Department of Internal MedicineSeoul National University College of Medicine, SMG-SNU Boramae Medical CenterSeoulRepublic of Korea

Personalised recommendations